APR 29·Stock Titan→
vTv Therapeutics (NASDAQ: VTVT) details 2026 virtual annual meeting, board and pay
vTv Therapeutics is holding its 2026 annual virtual-only meeting on June 10, 2026, where stockholders will vote on electing seven directors and ratifying Ernst & Young LLP as the independent auditor. The proxy statement details the company's governance structure, board composition, director compensation, and executive compensation for 2025, including CEO Paul Sekhri's $6.64 million total compensation and CFO Michael Tung's $2.44 million. Key investors, including MacAndrews & Forbes and several institutional investors, hold significant stakes and have board nomination rights.
MAR 12·Benzinga→
This Jabil Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
This article details five new analyst initiations on various stocks, including Jabil, Rush Street Interactive, Enovix, Planet Fitness, and vTv Therapeutics. Baird initiated coverage on Jabil with an Outperform rating and a $275 price target, while other analysts issued ratings ranging from Buy to Neutral for the other companies. These initiations offer investors fresh perspectives and price targets for these companies.
